metaiodobenzylguanidine


Also found in: Acronyms.

metaiodobenzylguanidine

(mĕt″ă-ī-ō″dō-bĕn″zĭl-gwah′nĭ-dēn″),

MIBG

A precursor of a neurotransmitter that is used for a variety of nuclear medicine studies, including the detection of neuroectodermal tumors (e.g., neuroblastoma or pheochromocytoma) and myocardial perfusion imaging.
References in periodicals archive ?
Yamamoto et al., "Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease," European Journal of Neurology, vol.
Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation.
u231 Metaiodobenzylguanidine and iii In octreotide uptake in benign and malignant pheochromocytomas.
Imaging the heart using a nuclear-tagged norepinephrine analogue, metaiodobenzylguanidine (MIBG), allows researchers to assess myocardial innervation and the abnormal denervation that's associated with pathology.
Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction.
An upper abdominal extralobar sequestration must be distinguished from a suprarenal neuroblastoma, which lacks systemic arterial supply and demonstrates metaiodobenzylguanidine (MIBG) uptake on nuclear scintigraphy.
Metaiodobenzylguanidine scintigraphy and single-photon emission CT showed increased uptake in the right adrenal gland (Figure 1(b)).
in their paper "A Comparative Assessment of Cardiovascular Autonomic Reflex Testing and Cardiac 123I-Metaiodobenzylguanidine Imaging in Patients with Type 1 Diabetes Mellitus without Complications or Cardiovascular Risk Factors" compared the diagnostic performance of cardiovascular autonomic reflex tests with that of sympathetic innervation heart imaging with 123I metaiodobenzylguanidine for cardiac autonomic neuropathy in type 1 DM.
Matthay, "Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma," Nuclear Medicine and Biology, vol.